“Judy’s Walk” is named for Binghamton High School teacher Judy Talbot, who died of lung cancer in 2005. The event will benefit the Michael E. Connolly Endowment for Lung Cancer Research. Connelly, a former student of Mrs. Talbot, died of lung cancer in 2002.

Cancer Care Ontario officials plan on stepping on a few hospital administrators’ toes over the next two years to reduce the death rate among those receiving lung and esophageal cancer surgeries.

Rosetta Genomics Ltd. announced April 23 that it has partnered with the New York University Medical Center with the aim of developing a line of early detection diagnostic products for lung and mesothelioma cancers. 

 

The early detection test will mainly target more than 45 million Americans who are at an increased risk of lung cancer due to smoking, as well as those who have been exposed to asbestos fibers. The test will utilize Rosetta Genomics’ proprietary protocol to extract microRNAs from a simple blood draw. 

Despite improvements, cancer cuts a wider swath in Louisiana compared to the rest of the country.

The upstate man who hit a million-dollar state lottery jackpot a month after being diagnosed with terminal lung cancer has died.Friends of 50-year-old Wayne Schenk tell the Canandaigua Daily Messenger that he died last evening at a Syracuse hospital.

Researchers at the Ireland Cancer Center of University Hospitals Case Medical Center have developed methods for treating lung cancer cells that have become resistant to new anti-cancer agents.

An article published by the British Medical journal reveals that there has been a tremendous increase in the number of cases of cancer in the Asian region. This has become a major strain on the already burdened health system.

Andrew Hill, a jazz pianist who played with some of the genre’s biggest legends, died on Friday of lung cancer. He was 75.Hill’s death was announced in a statement by Blue Note Records, with whom the pianist recorded for 44 years.

Pharmacyclics, Inc. today announced that the U.S. Food and Drug Administration (FDA) has filed the company’s New Drug Application (NDA) for Xcytrin(R) (motexafin gadolinium) Injection. The Prescription Drug User Fee Act (PDUFA) date for completion of review by FDA is December 31, 2007. The Company is seeking approval to market the drug for the treatment of non-small cell lung cancer (NSCLC) patients with brain metastases (i.e., cancer that has spread to the brain from another part of the body).

Rosetta Genomics, Ltd.  announced today that it has partnered with NYU Medical Center with the aim of developing a line of early detection diagnostic products for lung, and Mesothelioma cancers.